View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Pharmacology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 10, 2024
2 min read
Save

Studies show ChatGPT provides reliable information on vaccines, STIs

Studies show ChatGPT provides reliable information on vaccines, STIs

ChatGPT could help reduce vaccine hesitancy and provide accurate information on sexually transmitted infections, according to two new studies.

SPONSORED CONTENT
April 05, 2024
2 min read
Save

Mpox vaccine now available at pharmacies, physician offices

Mpox vaccine now available at pharmacies, physician offices

An mpox vaccine is now commercially available in the United States, expanding the locations where patients can access the shot to include pharmacies, physician offices and other facilities that normally vaccinate.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
April 04, 2024
2 min read
Save

FDA approves antibiotic to treat three bacterial infections

FDA approves antibiotic to treat three bacterial infections

The FDA this week approved the antibiotic Zevtera for the treatment of three bacterial infections 17 years after it was first submitted to the agency.

SPONSORED CONTENT
March 29, 2024
2 min read
Save

Moderna announces positive interim results for next-generation COVID-19 vaccine

Moderna announces positive interim results for next-generation COVID-19 vaccine

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

SPONSORED CONTENT
March 20, 2024
1 min read
Save

FDA approves aprocitentan for treatment of hypertension in adults with uncontrolled BP

FDA approves aprocitentan for treatment of hypertension in adults with uncontrolled BP

Idorsia announced that the FDA has approved aprocitentan, its antihypertensive drug, for treatment of hypertension in combination with other drugs in patients whose BP is not adequately controlled on other drugs.

SPONSORED CONTENT
March 14, 2024
2 min read
Save

‘Essential first step’: HIV study demonstrates potential of long-acting ART in Africa

‘Essential first step’: HIV study demonstrates potential of long-acting ART in Africa

DENVER — Long-acting ART was shown to be safe and effective in a study conducted in sub-Saharan Africa — an “essential first step” in demonstrating its potential use to treat HIV on the continent, an expert said.

SPONSORED CONTENT
March 09, 2024
2 min watch
Save

VIDEO: People who struggle with daily HIV regimen should be offered long-acting injections

VIDEO: People who struggle with daily HIV regimen should be offered long-acting injections

DENVER — People with HIV who have challenges adhering to a daily oral regimen should be offered long-acting formulations of ART, study findings suggest.

SPONSORED CONTENT
March 08, 2024
2 min read
Save

Semaglutide 2.4 mg approved to prevent CV events in patients with overweight, obesity

Semaglutide 2.4 mg approved to prevent CV events in patients with overweight, obesity

Novo Nordisk and the FDA announced approval of a new indication for semaglutide 2.4 mg for reduction of risk for major adverse cardiovascular events in adults with overweight or obesity and established CVD.

SPONSORED CONTENT
March 06, 2024
2 min read
Save

Having access to long-acting option increased PrEP coverage in Ugandan study

Having access to long-acting option increased PrEP coverage in Ugandan study

DENVER — Giving patients the option of choosing long-acting PrEP resulted in a fivefold increase in coverage and a reduction in HIV incidence during the SEARCH trial in Uganda, researchers reported.

SPONSORED CONTENT
March 06, 2024
2 min read
Save

Investigational two-drug regimen safe, effective for patients with HIV

Investigational two-drug regimen safe, effective for patients with HIV

DENVER — Phase 2 study data showed that a once-weekly oral regimen of an investigational two-drug HIV treatment was well tolerated among patients with HIV and allowed them to maintain viral suppression.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails